Raltegravir

ATC Code J05AJ01

Raltegravir

Definition

A small molecule with activity against human immunodeficiency virus (HIV). Raltegravir is an integrase inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV.

Also known as MK-0518, N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide, RALTEGRAVIR — per NCIT

Also identified as

Indications

Disease Relation Source
HIV infectious disease may treat MEDRT · Public domain (U.S. Government work)